Imagine it is 2030. Doctors in a regional hospital in country X note an expanding cluster of individuals with severe respiratory disease. Rapid whole-genome sequencing identifies the disease-causing agent as a novel coronavirus.
Epidemiological investigations suggest the virus is highly infectious, with most initial cases requiring hospitalisation. The episode bears a striking resemblance to the COVID outbreak first detected in December 2019.
Regional and national health authorities are notified quickly. The national contact point for the International Health Regulations 2024 (a major revision to the current IHR 2005) sends a description to the World Health Organization (WHO). After an intense exchange of information and risk assessment, it declares a public health emergency of international concern.
The outbreak is assigned a response strategy of “elimination”. This designation initiates a well-rehearsed procedure, including mobilising expertise and resource stockpiles.
The elimination response results in localised quarantine measures at the epicentre and its surrounds and a travel freeze across a wide radius within country X and at its borders. It also prompts intensified local and international surveillance. Case numbers rise rapidly but plateau after three weeks, and then fall until no new cases are detected in the community.
After eight weeks of intensive efforts the outbreak is over – similar to the experience of New Zealand, which terminated its initial COVID outbreak in eight weeks using an elimination strategy. The outbreak had spread regionally within country X, but not internationally.
This is how we propose, in The Lancet, the world should respond to future pandemic threats.
An upgraded pandemic response to eliminate at source
The process by which the WHO currently decides whether to declare a public health emergency of international concern (under the International Health Regulations 2005) has drawn criticism for being too slow.
The upgraded response framework we propose would enhance the existing risk assessment by routinely requiring WHO to assign a high-level response strategy for managing this risk. For potential pandemics, we consider this strategy should be elimination rather than suppression or mitigation, which have been the usual default options in the past. In simple terms, “if in doubt, stamp it out.”
The idea of eliminating novel emerging infectious diseases at the earliest possible stage is intuitively appealing and not new. It has been proposed for eliminating novel pandemic influenza outbreaks.
This approach successfully eliminated and then eradicated the SARS pandemic in 2003 (caused by SARS-CoV). It also proved successful in China during early containment of COVID in Wuhan.
We have described this concept previously. Whether this approach could have eliminated and ultimately eradicated COVID, if pursued early and in a co-ordinated way globally, remains a topic of speculation.
An elimination strategy also slows the spread of infection
There is a second broad reason for the WHO assigning an explicit strategic goal of elimination to pandemic diseases with sufficient severity. It can also slow or interrupt the global spread of a new infectious disease. This action buys time for interventions to be developed, building on rapidly accumulating scientific knowledge.
Some countries in the Asia-Pacific region adopted elimination and strong suppression strategies. This approach largely prevented widespread COVID circulation for the first one to two years of the pandemic, keeping mortality rates low.
It allowed time for vaccine development and roll-out and for jurisdictions to prepare their health systems for managing large numbers of infected people. Notable examples are New Zealand, Australia and Singapore. They have been able to keep their cumulative mortality low by international standards.
![This world map shows that cumulative numbers of deaths in countries.](https://images.theconversation.com/files/505011/original/file-20230117-11910-vgmyqo.jpg?ixlib=rb-1.1.0&q=45&auto=format&w=754&fit=clip)
If elimination is ultimately not successful or justifiable, an organised transition to another strategy (suppression or mitigation) should be considered. Processes for managing these transitions can draw on experience from the current pandemic.
Elimination makes sense for other potential pandemics
The most recently declared public health emergency of international concern is mpox (formerly known as monkeypox). Under our proposed change to the International Health Regulations, the WHO would have been required to assign a response strategy to this disease.
Elimination again makes sense as a default approach. That is what countries around the world have effectively been doing. And this approach appears to be working.
The other current public health emergency of international concern is poliomyelitis. Unlike COVID and mpox, this disease is already subject to a global eradication goal.
A further benefit of the elimination strategy is that it supports strengthening of health system infrastructure in low and middle-income countries. This capacity building has contributed to the elimination of periodic Ebola outbreaks in Africa, which have been designated as public health emergencies of international concern in 2014-16 and 2019-20. It could also support elimination of mpox, an increasing threat in Africa.
Upgraded International Health Regulations could stimulate a huge global investment in infrastructure to stop epidemics at source and improve surveillance capacity. These capacities are critical given the range of future pandemic scenarios, including the threat from bioweapons with advances in synthetic biology.
Let us hope that when the world is next confronted by the spark of a new emerging infectious disease with pandemic potential, the WHO rapidly declares a public health emergency of international concern and assigns an elimination strategy. And the international community reacts vigorously to extinguish the spark before it becomes an inferno.
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
The Silent Battle Within: How Your Organs Choose Between Mom and Dad’s Genes
Research reveals that selective expression of maternal or paternal X chromosomes varies by organ, driven by cellular competition. A new study published today (July 26) in Nature Genetics by the Lymphoid Development Group at the MRC [...]
Study identifies genes increasing risk of severe COVID-19
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in [...]
Small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa
Sleep and wake: They're totally distinct states of being that define the boundaries of our daily lives. For years, scientists have measured the difference between these instinctual brain processes by observing brain waves, with [...]
Redefining Consciousness: Small Regions of the Brain Can Take Micro-Naps While the Rest of the Brain Is Awake
The study broadly reveals how fast brain waves, previously overlooked, establish fundamental patterns of sleep and wakefulness. Scientists have developed a new method to analyze sleep and wake states by detecting ultra-fast neuronal activity [...]
AI Reveals Health Secrets Through Facial Temperature Mapping
Researchers have found that different facial temperatures correlate with chronic illnesses like diabetes and high blood pressure, and these can be detected using AI with thermal cameras. They highlight the potential of this technology [...]
Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice
In a recent study published in the journal Nature, a team of researchers used murine models and various pharmacological and genetic approaches to examine whether pro-inflammatory signaling involving interleukin (IL)-11, which activates signaling molecules such [...]
Promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus. The study, [...]
New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do neurons respond to the effects of magic mushrooms? What [...]
Decoding the Decline: Scientific Insights Into Long COVID’s Retreat
Research indicates a significant reduction in long COVID risk, largely due to vaccination and the virus’s evolution. The study analyzes data from over 441,000 veterans, showing lower rates of long COVID among vaccinated individuals compared [...]
Silicon Transformed: A Breakthrough in Laser Nanofabrication
A new method enables precise nanofabrication inside silicon using spatial light modulation and laser pulses, creating advanced nanostructures for potential use in electronics and photonics. Silicon, the cornerstone of modern electronics, photovoltaics, and photonics, [...]
Caught in the actinium: New research could help design better cancer treatments
The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don't have a good grasp on the metal's chemistry. That's because actinium [...]
Innovative Light-Controlled Drugs Could Revolutionize Neuropathic Pain Treatment
A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be harnessed to target drugs to specific [...]
Green Gold: Turning E-Waste Into a Treasure Trove of Rare Earth Metals
Scientists are developing a process inspired by nature that efficiently recovers europium from old fluorescent lamps. The approach could lead to the long-awaited recycling of rare earth metals. A small molecule that naturally serves [...]
Cambridge Study: AI Chatbots Have an “Empathy Gap,” and It Could Be Dangerous
A new study suggests a framework for “Child Safe AI” in response to recent incidents showing that many children perceive chatbots as quasi-human and reliable. A study has indicated that AI chatbots often exhibit [...]
Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy
Up to 3% of people with diabetes have an allergic reaction to insulin. A team at Forschungszentrum Jülich has now studied a method that could be used to deliver the active substance into the [...]
Nanorobot kills cancer cells in mice with hidden weapon
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice. The robot's weapon is hidden in a nanostructure and is exposed only in the tumor microenvironment, sparing healthy cells. [...]